KATHMANDU, JANUARY 2
The Department of Drug Administration (DDA) has ordered the recall of a batch of the antibiotic Levoflox-500 tablets after laboratory tests found the drug failed to meet quality standards.
According to a notice issued on Friday, tablets bearing batch number BB-24001, manufactured by Magnus Pharma Pvt Ltd, have been withdrawn from the market. The drug is commonly used to treat bacterial infections.
The department has instructed all stakeholders not to recommend, sell, distribute, or use the affected batch.
The decision follows sample testing conducted at the National Drug Laboratory, which found the batch to be substandard. Acting under Section 14 of the Drug Act, 2035 BS, the DDA has suspended the sale and distribution of the drug and directed an immediate market recall.
Manufacturers and distributors have been instructed to submit recall records to the department. The notice has been issued to inform pharmaceutical companies and their authorised representatives.
